FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
News|Slideshows|February 1, 2017
New Hypertension Guidelines: 7 Highs and Lows
Author(s)Leo Robert
The ACP and AAFP provide evidence-based recommendations on the benefits and harms of higher vs lower systolic blood pressure targets.
Advertisement
A new hypertension guideline is aimed at presenting evidence-based recommendations on the benefits and harms of higher (
Advertisement
Related to this article
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Advertisement
Advertisement
Trending on Patient Care Online
1
Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A
2
Elinzanetant Linked to Broad Improvements in Sleep Disturbance in Women With Moderate-to-Severe Vasomotor Symptoms
3
Insulin Resistance May Partly Explain Higher Cardiovascular Risk After Premature Menopause
4
AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026
5